BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21984123)

  • 1. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.
    Bennani-Baiti IM; Aryee DN; Ban J; Machado I; Kauer M; Mühlbacher K; Amann G; Llombart-Bosch A; Kovar H
    J Pathol; 2011 Nov; 225(3):353-63. PubMed ID: 21984123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma.
    Ban J; Bennani-Baiti IM; Kauer M; Schaefer KL; Poremba C; Jug G; Schwentner R; Smrzka O; Muehlbacher K; Aryee DN; Kovar H
    Cancer Res; 2008 Sep; 68(17):7100-9. PubMed ID: 18757425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of KCMF1 by constitutive high CD99 expression is involved in the migratory ability of Ewing's sarcoma cells.
    Kreppel M; Aryee DN; Schaefer KL; Amann G; Kofler R; Poremba C; Kovar H
    Oncogene; 2006 May; 25(19):2795-800. PubMed ID: 16314831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.
    Uren A; Merchant MS; Sun CJ; Vitolo MI; Sun Y; Tsokos M; Illei PB; Ladanyi M; Passaniti A; Mackall C; Toretsky JA
    Oncogene; 2003 Apr; 22(15):2334-42. PubMed ID: 12700668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EWS-FLI-1 expression triggers a Ewing's sarcoma initiation program in primary human mesenchymal stem cells.
    Riggi N; Suvà ML; Suvà D; Cironi L; Provero P; Tercier S; Joseph JM; Stehle JC; Baumer K; Kindler V; Stamenkovic I
    Cancer Res; 2008 Apr; 68(7):2176-85. PubMed ID: 18381423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness.
    Zhang P; Yang Y; Nolo R; Zweidler-McKay PA; Hughes DP
    Oncogene; 2010 May; 29(20):2916-26. PubMed ID: 20208568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch signal activates hypoxia pathway through HES1-dependent SRC/signal transducers and activators of transcription 3 pathway.
    Lee JH; Suk J; Park J; Kim SB; Kwak SS; Kim JW; Lee CH; Byun B; Ahn JK; Joe CO
    Mol Cancer Res; 2009 Oct; 7(10):1663-71. PubMed ID: 19808903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
    Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
    Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
    Katoh M; Katoh M
    Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells.
    Tirado OM; Mateo-Lozano S; Villar J; Dettin LE; Llort A; Gallego S; Ban J; Kovar H; Notario V
    Cancer Res; 2006 Oct; 66(20):9937-47. PubMed ID: 17047056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex interplay between β-catenin signalling and Notch effectors in intestinal tumorigenesis.
    Peignon G; Durand A; Cacheux W; Ayrault O; Terris B; Laurent-Puig P; Shroyer NF; Van Seuningen I; Honjo T; Perret C; Romagnolo B
    Gut; 2011 Feb; 60(2):166-76. PubMed ID: 21205878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cooperative functions of Hes/Hey genes in auditory hair cell and supporting cell development.
    Tateya T; Imayoshi I; Tateya I; Ito J; Kageyama R
    Dev Biol; 2011 Apr; 352(2):329-40. PubMed ID: 21300049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple roles of Notch signaling in the regulation of epidermal development.
    Moriyama M; Durham AD; Moriyama H; Hasegawa K; Nishikawa S; Radtke F; Osawa M
    Dev Cell; 2008 Apr; 14(4):594-604. PubMed ID: 18410734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of nuclear expression of hairy and enhancer of split-1 (HES1) in pancreatic endocrine tumors.
    Johansson T; Lejonklou MH; Ekeblad S; Stålberg P; Skogseid B
    Horm Metab Res; 2008 May; 40(5):354-9. PubMed ID: 18491256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin Inhibits Proliferation of Osteosarcoma Cells Through Upregulation of the Notch Signaling Pathway.
    Ji P; Yu L; Guo WC; Mei HJ; Wang XJ; Chen H; Fang S; Yang J
    Oncol Res; 2014; 22(4):185-191. PubMed ID: 26351207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
    Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
    J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CDKN1C/P57 is regulated by the Notch target gene Hes1 and induces senescence in human hepatocellular carcinoma.
    Giovannini C; Gramantieri L; Minguzzi M; Fornari F; Chieco P; Grazi GL; Bolondi L
    Am J Pathol; 2012 Aug; 181(2):413-22. PubMed ID: 22705236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HES1 promotes metastasis and predicts poor survival in patients with colorectal cancer.
    Yuan R; Ke J; Sun L; He Z; Zou Y; He X; Chen Y; Wu X; Cai Z; Wang L; Wang J; Fan X; Wu X; Lan P
    Clin Exp Metastasis; 2015 Feb; 32(2):169-79. PubMed ID: 25636905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.